Zur Kurzanzeige

dc.contributor.authorAmaral, Ana Teresa
dc.contributor.authorOrdóñez García, José Luis 
dc.contributor.authorOtero Motta, Ana Pastora
dc.contributor.authorGarcía Domínguez, Daniel José
dc.contributor.authorSevillano, María Victoria
dc.contributor.authorde Álava Casado, Enrique
dc.date.accessioned2024-01-18T09:47:43Z
dc.date.available2024-01-18T09:47:43Z
dc.date.issued2014-01
dc.identifier.citationAmaral, A. T., Ordóñez, J. L., Otero-Motta, A. P., García-Domínguez, D. J., Sevillano, M. V., & de Álava, E. (2014). Innovative therapies in Ewing sarcoma. Advances in Anatomic Pathology, 21(1), 44-62. doi:10.1097/PAP.0000000000000003es_ES
dc.identifier.issn1072-4109
dc.identifier.urihttp://hdl.handle.net/10366/154368
dc.description.abstract[EN]Ewing Sarcoma is a developmental tumor characterized by balanced chromosomal translocations and formation of new fusion genes, which are the main hallmark of this rare entity. Despite the vast knowledge regarding the molecular aspects of this rare malignancy obtained in the last few years, including the discovery of new therapeutic targets, many questions still remain open. In this review we focus on the research on targeted therapies in this malignancy, and discussed some bottlenecks related to this such as the possible role of pathologists, the availability of samples, the lack of appropriate animal models, and the resources needed to carry out preclinical and clinical research.es_ES
dc.description.sponsorshipE. de Álava's laboratory is supported by the AECC (Asociación Española contra el Cáncer), the Ministry of Economy and Competitivity of Spain-FEDER (PI081828, RD06/0020/0059 RD12/0036/0017, PT13/0010/0056, PI110018, ISCIII Sara Borrell postdoc grant CD06/00001), and Fundación Memoria de D. Manuel Solorzano Barruso, Fundación Cris contra el cancer, and Fundación María García Estrada. J.L. Ordóñez is sponsored by the CSIC and the European Social Fund (postdoctoral grant JAE DOC), A.T. Amaral is sponsored by the Fundaçao para a Ciência e Tecnologia, Portugal (fellowship SFRH/BD/69318/2010)es_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.publisherLippincottes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectEwing sarcomaes_ES
dc.subjectTherapyes_ES
dc.subjectClinical trialses_ES
dc.subjectAnimal modeles_ES
dc.titleInnovative Therapies in Ewing Sarcomaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.1097/PAP.0000000000000003
dc.relation.projectIDPI081828es_ES
dc.relation.projectIDRD12/0036/0017es_ES
dc.relation.projectIDPI110018es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.journal.titleAdvances in Anatomic Pathologyes_ES
dc.volume.number21es_ES
dc.issue.number1es_ES
dc.page.initial44es_ES
dc.page.final62es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 Internacional